Article ID Journal Published Year Pages File Type
5568012 Health SA Gesondheid 2017 11 Pages PDF
Abstract
While numerous studies regarding pharmacological and immunological research have identified new treatment options, there is a dearth of clinical studies to discover the biomarkers and immune therapeutic management to control sensitisation and effector phases of this condition. Given the complexity of this condition due to the multifactorial nature of the possible aetiologies, rigorous well-designed scientific studies are needed to determine the exact classification, prevalence and underlying immune pathological processes of ocular allergy.
Related Topics
Health Sciences Nursing and Health Professions Nursing
Authors
,